Alqahtani, A.M.S.; Kadasah, S.F.; Radwan, M.O. Pancreatic Cancer Management by Pentacyclic Triterpenes. Preprints2024, 2024021741. https://doi.org/10.20944/preprints202402.1741.v1
APA Style
Alqahtani, A.M.S., Kadasah, S.F., & Radwan, M.O. (2024). Pancreatic Cancer Management by Pentacyclic Triterpenes. Preprints. https://doi.org/10.20944/preprints202402.1741.v1
Chicago/Turabian Style
Alqahtani, A.M.S., Sultan F. Kadasah and Mohamed O. Radwan. 2024 "Pancreatic Cancer Management by Pentacyclic Triterpenes" Preprints. https://doi.org/10.20944/preprints202402.1741.v1
Abstract
Pancreatic cancer (PC) is considered one of the most challenging and formidable malig-nancies to treat because it is usually diagnosed at terminal stage, thus it is characterized with a poor prognosis with 5% of patients living over 5 years. The late diagnosis leads to a lower suc-cess rate of resectability, hence chemotherapy or chemoradiotherapy are the only hopes for most PC patients. However, the available drug combinations for PC treatment did not provide satisfactory clinical outcomes. There is a pressing and urgent need to discover new chemothera-peutics which fight PC with tolerable side effects and less liability for resistance. Pentacyclic triterpenes (PTs) are privileged structures with a multitude of biological activities mitigating several ailments, particularly in neoplasm field. They are characterized by a high therapeutic window and their activity can be highly enhanced through structural modifications. Indeed, several parent PTs such as oleanolic acid, ursolic acid, lupeol, betulinic acid, and celastrol proved effective against different PC phenotypes inhibiting their proliferation, invasion, and metastasis mainly via KRAS modulation. Some PTs worked as adjuvant chemosensitizers in gemcitabine-resistant or TRAIL-resistant cells. Owing to their potential in PC treatment, we pre-sent this review article summarizing PC pathogenesis and the promising role of PTs in the man-agement of PC when used either solely or in combination with other chemotherapies such as gemcitabine and 5-Fluorouracil.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
